摘要
作者建立了血清前列腺特异抗原(PSA)的生物素-亲和素酶联免疫(BA-ELISA)测定法并用于临床。测定结果表明,合并前列腺急或慢性炎症患者的血清PSA水平显著高于单纯前列腺增生患者。以10ng/ml为界值诊断前列腺癌,其敏感性为62.96%,特异性为91.81%。我们用自建的BA-ELISA法和进口试剂盒Tandem-E法平行测定了良性前列腺增生组的血清PSA水平,结果表明BA-ELISA法用于临床比Tandem-E法更灵敏、更经济。
AbstractSerum prostate specific antigen(PSA)-the biotin-avidin enzym immunoassay(BA-ELISA)was estab-lished and used in clinical practice.We assayed serumPSA in normal control and prostatic patients. If 10ng/ml was taken as the cutoff value,the positive rate ofprostatic cancer was 62. 96%.The results of determi-nation showed:PSA serum levels of patients with com-plicated BPH(acute prostatitis and chronic prostatitis )were conspicuously higher than the noncomplicatedBPH.In the BPH group,we simultaneously detectedserum levels of PSA by BA-ELISA and Tandem-EPSAImmuno Enzy Metric Assay.The results suggestedBA-ELISA technique is more sensitive and more eco-nomical than Tandem-EPSA Immuno Enzy Metric AS-say for clinical use.
出处
《中华外科杂志》
CAS
CSCD
北大核心
1994年第11期685-687,共3页
Chinese Journal of Surgery